透析行业整合、患者选择与本地市场竞争
研究基于美国国家终末期肾病登记系统,比较2001年与2011年接受中心血液透析患者的透析机构所有权及选择范围。结果显示,尽管两家营利性公司服务超过70%患者,独特所有竞争提供者数量减少8%,但透析机构数量增加54%,患者可选就近竞争机构平均增加10%(P<0.001),本地市场集中度未实质性变化。
要点
- 2001至2011年间,独特所有竞争透析提供者数量减少8%。
- 美国透析机构数量增加54%,患者可选就近竞争机构平均增加10%(P<0.001)。
- 本地市场高度集中,两年平均赫芬达尔-赫希曼指数均为0.46(标准差=0.2),总体集中度未实质性变化。
核心结论
- 美国透析行业十年整合平均未限制患者选择,也未导致本地市场更加集中。
- 由于透析市场仍高度集中,需了解市场竞争是否影响私人保险公司支付价格、透析可及性、照护质量及相关健康结局。
研究设计与样本
- 从国家终末期肾病登记系统识别2001年初和2011年初接受中心血液透析的患者,并确定透析机构所有权。
- 对每个医院服务区,确定2001年90%患者接受透析所行的最大距离。
- 比较2001年与2011年同一距离内竞争性透析提供者的数量。
- 检查每个医院服务区的赫芬达尔-赫希曼指数,该指标从接近零(完全竞争)到一(垄断)。
主要发现
- 2001年至2011年间,不同独特所有竞争提供者数量减少8%。
- 新机构进入市场以满足不断增长的照护需求,抵消了提供者整合对患者可选选择数量的影响。
- 美国透析机构数量增加54%,患者可选就近竞争机构数量平均增加10%(P<0.001)。
- 2001年和2011年本地市场均高度集中(平均赫芬达尔-赫希曼指数=0.46;两年标准差均为0.2),但总体市场集中度未实质性变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Medicare program insures >80% of patients with ESRD in the United States. An emphasis on reducing outpatient dialysis costs has motivated consolidation among dialysis providers, with two for-profit corporations now providing dialysis for >70% of patients. It is unknown whether industry consolidation has affected patients' ability to choose among competing dialysis providers. We identified patients receiving in-center hemodialysis at the start of 2001 and 2011 from the national ESRD registry and ascertained dialysis facility ownership. For each hospital service area, we determined the maximum distance within which 90% of patients traveled to receive dialysis in 2001. We compared the numbers of competing dialysis providers within that same distance between 2001 and 2011. Additionally, we examined the Herfindahl-Hirschman Index, a metric of market concentration ranging from near zero (perfect competition) to one (monopoly) for each hospital service area. Between 2001 and 2011, the number of different uniquely owned competing providers decreased 8%. However, increased facility entry into markets to meet rising demand for care offset the effect of provider consolidation on the number of choices available to patients. The number of dialysis facilities in the United States increased by 54%, and patients experienced an average 10% increase in the number of competing proximate facilities from which they could choose to receive dialysis (P<0.001). Local markets were highly concentrated in both 2001 and 2011 (mean Herfindahl-Hirschman Index =0.46; SD=0.2 for both years), but overall market concentration did not materially change. In summary, a decade of consolidation in the United States dialysis industry did not (on average) limit patient choice or result in more concentrated local markets. However, because dialysis markets remained highly concentrated, it will be important to understand whether market competition affects prices paid by private insurers, access to dialysis care, quality of care, and associated health outcomes.
引用
- Erickson KF, Zheng Y, Winkelmayer WC, et al. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2016. PMID: 27831510. doi:10.2215/CJN.06340616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。